Prolife Industries Ltd
Incorporated in 1994, Prolife Industries Ltd manufactures intermediates for dyes, pigments, pharmaceuticals, agrochemicals, etc.[1]
- Market Cap ₹ 28.2 Cr.
- Current Price ₹ 69.0
- High / Low ₹ 165 / 56.0
- Stock P/E 6.65
- Book Value ₹ 121
- Dividend Yield 0.43 %
- ROCE 12.2 %
- ROE 8.94 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.57 times its book value
Cons
- The company has delivered a poor sales growth of -5.80% over past five years.
- Company has a low return on equity of 13.9% over last 3 years.
- Earnings include an other income of Rs.2.84 Cr.
- Debtor days have increased from 54.0 to 71.8 days.
- Working capital days have increased from 69.6 days to 110 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Dyes And Pigments
Part of Nifty SME Emerge
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 19.58 | 22.19 | 27.14 | 27.20 | 29.58 | 50.38 | 73.50 | 73.08 | 78.15 | 56.81 | 55.35 | 54.52 | |
| 17.76 | 20.39 | 24.60 | 23.65 | 25.38 | 44.82 | 65.28 | 67.10 | 69.41 | 45.00 | 49.67 | 50.42 | |
| Operating Profit | 1.82 | 1.80 | 2.54 | 3.55 | 4.20 | 5.56 | 8.22 | 5.98 | 8.74 | 11.81 | 5.68 | 4.10 |
| OPM % | 9.30% | 8.11% | 9.36% | 13.05% | 14.20% | 11.04% | 11.18% | 8.18% | 11.18% | 20.79% | 10.26% | 7.52% |
| 0.31 | 0.45 | 0.10 | 0.27 | 0.46 | 1.78 | 0.62 | 1.63 | 2.18 | 1.59 | 2.08 | 2.84 | |
| Interest | 1.11 | 1.01 | 0.84 | 0.84 | 0.91 | 0.63 | 0.52 | 0.48 | 0.43 | 0.33 | 0.34 | 0.09 |
| Depreciation | 0.40 | 0.42 | 0.47 | 0.89 | 0.93 | 1.03 | 0.93 | 1.16 | 1.25 | 1.21 | 1.10 | 0.98 |
| Profit before tax | 0.62 | 0.82 | 1.33 | 2.09 | 2.82 | 5.68 | 7.39 | 5.97 | 9.24 | 11.86 | 6.32 | 5.87 |
| Tax % | 37.10% | 35.37% | 33.83% | 28.23% | 28.01% | 28.87% | 25.58% | 27.97% | 25.11% | 26.14% | 25.79% | 27.43% |
| 0.40 | 0.53 | 0.87 | 1.50 | 2.04 | 4.04 | 5.50 | 4.30 | 6.91 | 8.76 | 4.68 | 4.25 | |
| EPS in Rs | 2.68 | 3.55 | 2.13 | 3.66 | 4.98 | 9.87 | 13.43 | 10.50 | 16.88 | 21.40 | 11.43 | 10.38 |
| Dividend Payout % | 8.94% | 7.03% | 9.40% | 6.82% | 6.01% | 3.04% | 2.23% | 2.85% | 1.78% | 2.33% | 2.62% | 2.89% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | -6% |
| 3 Years: | -11% |
| TTM: | -2% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | -5% |
| 3 Years: | -15% |
| TTM: | -9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -8% |
| 3 Years: | -36% |
| 1 Year: | -53% |
| Return on Equity | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 16% |
| 3 Years: | 14% |
| Last Year: | 9% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.49 | 1.49 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
| Reserves | 1.53 | 2.10 | 4.59 | 6.00 | 8.03 | 11.92 | 17.30 | 21.48 | 28.27 | 36.90 | 41.38 | 45.51 |
| 10.10 | 8.61 | 5.07 | 4.82 | 7.15 | 7.71 | 5.49 | 4.71 | 1.92 | 3.81 | 2.58 | 0.27 | |
| 4.57 | 3.84 | 4.77 | 6.22 | 7.42 | 11.94 | 21.75 | 25.15 | 6.88 | 7.12 | 5.27 | 4.52 | |
| Total Liabilities | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 | 54.39 |
| 2.73 | 3.21 | 8.11 | 9.56 | 10.04 | 9.60 | 9.34 | 11.43 | 11.36 | 11.29 | 10.51 | 7.87 | |
| CWIP | 0.13 | 0.57 | 0.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.87 | 2.81 | 1.52 | 1.77 | 1.76 | 1.22 | 1.22 | 1.22 | 1.21 | 1.21 | 1.21 | 3.56 |
| 11.96 | 9.45 | 8.36 | 9.80 | 14.89 | 24.84 | 38.07 | 42.78 | 28.59 | 39.42 | 41.60 | 42.96 | |
| Total Assets | 17.69 | 16.04 | 18.52 | 21.13 | 26.69 | 35.66 | 48.63 | 55.43 | 41.16 | 51.92 | 53.32 | 54.39 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.02 | 4.15 | -0.08 | 5.84 | 0.81 | 10.02 | 5.11 | 3.73 | 0.05 | 17.33 | 0.33 | -1.64 | |
| -0.17 | -1.41 | -3.28 | -3.27 | -2.33 | -4.69 | -5.64 | -3.05 | 1.46 | 3.49 | -2.76 | 2.66 | |
| 0.47 | -2.86 | 3.30 | -1.86 | 1.63 | -3.74 | -1.31 | -0.14 | -1.43 | -0.72 | -1.69 | -2.32 | |
| Net Cash Flow | 0.33 | -0.13 | -0.06 | 0.71 | 0.10 | 1.58 | -1.84 | 0.54 | 0.08 | 20.11 | -4.12 | -1.31 |
| Free Cash Flow | -0.82 | 2.82 | -2.90 | 4.04 | -0.59 | 9.43 | 4.44 | 0.48 | -1.08 | 16.18 | 0.01 | -2.56 |
| CFO/OP | 15% | 249% | 17% | 180% | 38% | 210% | 85% | 91% | 27% | 173% | 35% | -1% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 62.64 | 63.66 | 57.56 | 38.11 | 100.44 | 52.16 | 78.46 | 83.76 | 49.55 | 34.44 | 55.79 | 71.77 |
| Inventory Days | 170.77 | 69.16 | 43.03 | 65.17 | 37.05 | 62.59 | 52.32 | 76.79 | 39.40 | 63.68 | 68.39 | 96.46 |
| Days Payable | 91.39 | 68.73 | 71.78 | 104.12 | 104.55 | 89.97 | 124.33 | 149.89 | 25.99 | 37.71 | 30.18 | 21.16 |
| Cash Conversion Cycle | 142.02 | 64.08 | 28.81 | -0.84 | 32.93 | 24.78 | 6.45 | 10.66 | 62.96 | 60.41 | 94.00 | 147.07 |
| Working Capital Days | 87.61 | 40.46 | 54.06 | 18.12 | 54.91 | 0.07 | 8.94 | 19.58 | 57.54 | 28.98 | 70.10 | 109.66 |
| ROCE % | 13.70% | 14.93% | 16.57% | 20.31% | 21.83% | 29.03% | 30.83% | 22.57% | 29.96% | 30.83% | 14.35% | 12.17% |
Insights
In beta| Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Export Sales INR Lakhs |
|
|||||||||||
| Gross Block - Plant and Machinery INR Lakhs |
||||||||||||
| Number of Permanent Employees Number |
||||||||||||
| Trade Receivables Turnover Ratio Ratio |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Disclosure under SEBI Takeover Regulations
15 June 2026 - Promoter group declared no encumbrance on 73.74% shareholding as of 31 March 2026.
-
Structural Digital Database
1 June 2026 - Submitted SDD compliance certificate for FY ended 31 March 2026; no non-compliances reported.
-
Appointment
29 May 2026 - Prolife Industries appointed Paresh V. Soni & Co. as internal auditor for FY 2026-27.
-
Outcome of Board Meeting
29 May 2026 - Board approved FY26 audited results; net profit Rs 425.39 lakh; appointed Paresh V. Soni & Co. as internal auditor.
-
Updates
30 April 2026 - Prolife confirms it is not a Large Corporate entity for FY2026 annual disclosure.
Business Overview:[1]
PIL manufactures a range of intermediates for dyes, pigments, pharmaceuticals, and agrochemicals industry